CompletedPhase 4NCT01542138

Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation

Studying Hyperpigmentation of the skin

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universidad Autonoma de San Luis Potosí
Principal Investigator
Bertha Torres-Alvarez, MD
Dermatology Department. Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosi, México
Intervention
Desonide(drug)
Enrollment
28 target
Eligibility
18-50 years · FEMALE
Timeline
20112012

Study locations (1)

Collaborators

Hospital Central "Dr. Ignacio Morones Prieto"

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01542138 on ClinicalTrials.gov

Other trials for Hyperpigmentation of the skin

Additional recruiting or active studies for the same condition.

See all trials for Hyperpigmentation of the skin

← Back to all trials